Better outcome of vascular accesses for hemodialysis patients

Renal failure requires chronic hemodialisis treatment with extracorporeal blood circulation. This in turn requires the execution of arm vessel surgery known as arteriovenous fistula. Currently these procedures are done relying almost exclusively on the surgeon experience. Even with skilled surgeons, however, a high percentage of patients experience complications that require reoperation.

The ARCH system makes possible to plan such surgery in advance on the basis of patient’s data, and obtain a prediction of the vascular access function outcome, allowing an optimisation of the surgical procedure and a reduction of associated complications such as non-maturation.

A prospective study is running coordinated by the Mario Negri Institue in Italy. Preliminary results on 63 patients confirm the efficacy of this technology. 

Bode A, Caroli A, Huberts W, Planken N, Antiga L, Bosboom M, Remuzzi A, Tordoir J. Clinical study protocol for the ARCH project - computational modeling for improvement of outcome after vascular access creation. J Vasc Access. 2011 Oct-Dec;12(4):369-76. doi: 10.5301/JVA.2011.8382.
Caroli A, Manini S, Antiga L, Passera K, Ene-Iordache B, Rota S, Remuzzi G, Bode A, Leermakers J, van de Vosse FN, Vanholder R, Malovrh M, Tordoir J, Remuzzi A. Validation of a patient-specific hemodynamic computational model for surgical planning of vascular access in hemodialysis patients. Kidney Int. 2013 Dec;84(6):1237-45. doi: 10.1038/ki.2013.188.
Public dissemination: Euronews coverage target also ARCH project www.euronews.com/2012/02/14/picture-my-body/

Avicenna Alliance news

The EESC calls for the creation of Good Simulation Practices

The European Economic and Social Affairs Committee (EESC) has specifically called for the creation of Good Simulation Practices as part...

find out more ›

Avicenna continues to grow by welcoming Altair among its members!

The Avicenna Alliance is proud to announce the newest addition to its list of members: Altair!

Altair is a global technology...

find out more ›

Avicenna provides feedback on the processing of personal health data in the EU

During the month of July, the Avicenna Alliance received the opportunity to provide its contribution to the European...

find out more ›

The European Medicines Agency has accepted the Avicenna Alliance's request to be directly involved in Agency activities

We are proud to announce that the European Medicines Agency (EMA) has accepted...

find out more ›

The Avicenna Alliance provided feedback on the Pharmaceutical Strategy for Europe

We are proud to announce that the Avicenna Alliance has submitted Members’ feedback to the European Commission’s...

find out more ›

Show all activites

Sign up for our monthly newsletter!


Sign up